Transdermal drug delivery companies focus on creating innovative methods for administering medications through the skin. This approach enhances patient compliance, allowing for consistent treatments without the discomfort associated with traditional injections. The companies in this sector range from startups to established players, working on various products like patches, microneedles, and films. As healthcare shifts towards personalized medicine, transdermal solutions are garnering attention for their potential benefits. Developing advanced delivery systems, such as those utilizing nanotechnology, is becoming increasingly relevant, responding to patients' needs for efficient and non-invasive therapies. An emphasis on research and collaboration promises exciting advancements ahead.

The companies highlighted in this listing vary in size from small teams to significant corporations. They are headquartered in locations such as the United States, Germany, and India, with founding years spanning more than three decades to recent startups. Focus areas include transdermal patches, injectables, and innovative drug delivery technologies. Each company brings unique expertise and specializes in different therapeutic areas, meeting rising demands within the healthcare industry for effective medical solutions. Collectively, they emphasize research, development, and efficient manufacturing processes to find novel drug delivery methods.

Continue reading to discover the top transdermal drug delivery companies.

Top 24 Transdermal Drug Delivery Companies

1. Biotts

• Website: biotts.com
• Ownership type: Venture Capital
• Headquarters: Żarów, Lower Silesian Voivodeship, Poland
• Employee distribution: Poland 100%
• Latest funding: October 2021
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: biotts

Biotts is a biotechnology firm based in Żarów, Poland, founded in 2018. The company focuses on developing transdermal drug delivery systems, utilizing its proprietary Multifunctional Transdermal Carrier Y (MTC-Y) technology. This innovative approach enables the delivery of both lipophilic and hydrophilic molecules, including larger compounds like peptides and proteins, through the skin. Biotts primarily collaborates with pharmaceutical companies and healthcare providers, aiming to enhance patient care through advanced drug delivery solutions. The company has made strides in the industry, recently achieving significant milestones such as obtaining a GMP license for manufacturing and conducting clinical trials. Their ongoing projects include developing transdermal insulin delivery systems, which could revolutionize diabetes management. Biotts has also been recognized in various publications, highlighting its potential impact in the biotech sector.

2. LTS Lohmann Therapie-Systeme AG

• Website: ltslohmann.com
• Ownership type: Private
• Headquarters: Andernach, Rhineland-Palatinate, Germany
• Employee distribution: Germany 59%, United States (USA) 28%, Israel 11%, Other 2%
• Founded year: 1984
• Headcount: 1001-5000
• LinkedIn: lts---lohmann-therapie-systems-ag

LTS Lohmann Therapie-Systeme AG, founded in 1984 and based in Andernach, Germany, is a pharmaceutical company that specializes in innovative drug delivery systems. The company focuses on transdermal therapeutic systems, oral thin films, and microneedle technologies, catering to pharmaceutical partners worldwide. With a workforce of over 1,000 employees, LTS is dedicated to research and development, process development, and manufacturing, ensuring high-quality solutions for the healthcare industry. Their transdermal systems are designed to improve patient compliance and therapeutic outcomes, making them a valuable partner for pharmaceutical companies. LTS has produced nearly 1.1 billion systems and holds over 200 patent families, showcasing their commitment to innovation and market presence. They have also expanded their capabilities through acquisitions, such as the purchase of Tapemark Inc. in 2022, further solidifying their position in the drug delivery sector.

3. Anodyne Nanotech, Inc

• Website: theheropatch.com
• Ownership type: Private
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2019
• Headcount: 11-50
• LinkedIn: hero-patch

Anodyne Nanotech, Inc., founded in 2019 and based in Boston, Massachusetts, is a private biotechnology firm dedicated to advancing drug delivery systems. The company specializes in the development of the Hero Patch, a transdermal delivery method that leverages proprietary microneedle technology to enhance the administration of biologics. This innovative approach allows for the delivery of clinically meaningful doses of medication while addressing common issues associated with traditional methods, such as injections and pills. Anodyne's technology aims to improve patient adherence and minimize side effects, making it an attractive option for pharmaceutical companies. The company has not reported any funding, indicating a focus on organic growth and development within the industry.

4. Noven Pharmaceuticals

• Website: noven.com
• Ownership type: Corporate
• Headquarters: Miami, Florida, United States (USA)
• Employee distribution: United States (USA) 99%, Other 1%
• Latest funding: July 2009
• Founded year: 1987
• Headcount: 201-500
• LinkedIn: noven-pharmaceuticals

Noven Pharmaceuticals, Inc. is a specialty pharmaceutical company based in Miami, Florida, dedicated to the research, development, manufacture, marketing, and sale of prescription pharmaceutical products. Established in 1987, Noven has carved out a niche in transdermal drug delivery systems, focusing on innovative solutions that enhance patient care. The company primarily targets therapeutic areas such as mental health and women's health, offering products like XELSTRYM® for ADHD, SECUADO® for schizophrenia, and various hormone therapy patches for menopausal health. Noven operates as a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., which is recognized as the largest manufacturer of transdermal patches globally. This relationship allows Noven to leverage advanced technologies and expertise in developing new transdermal systems, ensuring they remain at the forefront of the industry. Their commitment to improving patient outcomes through effective medication delivery is evident in their ongoing product development efforts and strategic partnerships.

5. Nemaura Pharma Limited

• Website: nemaura.co.uk
• Ownership type: Private
• Headquarters: Loughborough, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: $5.0M, February 2017
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: nemaura-pharma-limited

Nemaura Pharma Limited, based in Loughborough, England, is a private pharmaceutical company founded in 2005. The company specializes in advanced drug delivery technologies, particularly focusing on transdermal systems and injector devices. Nemaura Pharma aims to improve patient compliance and drug efficacy by offering innovative solutions that allow for the precise and minimally invasive delivery of medications. Their technologies are designed to overcome the limitations of traditional oral intake and injections, providing a more comfortable experience for patients. With a workforce of around 22 employees, Nemaura Pharma has developed a comprehensive pipeline of products and services, including investigational medicinal product manufacture and in-house stability studies. The company has also secured funding of £5 million in 2017, which supports its ongoing research and development efforts in the field of drug delivery. Nemaura Pharma's commitment to enhancing the delivery of both new and existing drugs positions them as a significant player in the pharmaceutical industry.

6. Medherant Limited

• Website: medherant.co.uk
• Ownership type: Venture Capital
• Headquarters: Coventry, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Latest funding: $3.6M, April 2023
• Founded year: 2015
• Headcount: 11-50
• LinkedIn: medherant-limited

Medherant Limited, founded in 2015 and based in Coventry, England, is a clinical-stage pharmaceutical company dedicated to advancing transdermal drug delivery systems. The company has developed the TEPI Patch technology, which utilizes a novel adhesive to create thin, flexible, and comfortable patches for drug delivery. Medherant's primary focus is on women's health, with their lead product being a testosterone patch designed for post-menopausal women. This patch aims to address the lack of approved testosterone products for women, a significant gap in the market. Medherant collaborates with pharmaceutical partners to enhance drug delivery methods and improve patient compliance. The company has recently secured funding of approximately £3.6 million in April 2023, reflecting strong investor confidence in their innovative approach and potential for growth in the transdermal drug delivery sector.

7. Tapemark

• Website: tapemark.com
• Ownership type: Corporate
• Headquarters: West Saint Paul, Minnesota, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: August 2022
• Founded year: 1952
• Headcount: 51-200
• LinkedIn: tapemark

Tapemark, founded in 1952 and based in West Saint Paul, Minnesota, is a pharmaceutical company that specializes in drug delivery systems. The company focuses on transdermal patch and oral film drug delivery, providing innovative solutions for pharmaceutical clients. Tapemark offers a range of services, including formulation, analytical services, and manufacturing, making it a full-service contract development and manufacturing organization (CDMO). Their proprietary platforms, such as IontoPatch™, MacroPerm™, and MicroDerm™, showcase their commitment to advancing drug delivery technologies. With a workforce of 51-200 employees, Tapemark has established itself as a reliable partner for pharmaceutical companies seeking effective drug administration methods. Their expertise in both transdermal and oral film drug delivery positions them as a significant player in the industry.

8. Amarin Technologies S.A.

• Website: amarintech.com
• Ownership type: Private
• Headquarters: Buenos Aires, Buenos Aires, Argentina
• Employee distribution: Argentina 100%
• Founded year: 1986
• Headcount: 11-50
• LinkedIn: amarin-technologies-s-a-

Amarin Technologies S.A. is a privately held pharmaceutical company based in Buenos Aires, Argentina, established in 1986. The company specializes in the development and formulation of topical and transdermal drug delivery systems. With over 30 years of experience, Amarin has built a reputation for providing innovative solutions that enhance medication adherence and effectiveness. They offer a range of services, including contract development, co-development, and out-licensing of their own developed products. Their manufacturing facility is equipped to handle all operations related to transdermal systems, from mixing to labeling, ensuring high-quality production standards. Amarin's product offerings include both generic versions of established drugs and proprietary formulations, showcasing their capability to adapt to market needs. The company has also engaged in technology transfers and partnerships with other pharmaceutical entities, further solidifying its role in the industry.

9. Luye Pharma AG

• Website: luyepharma.eu
• Ownership type: Private
• Headquarters: Miesbach, Bavaria, Germany
• Employee distribution: Germany 100%
• Founded year: 1997
• Headcount: 201-500
• LinkedIn: luye-pharma-ag

Luye Pharma AG, based in Miesbach, Bavaria, Germany, is a pharmaceutical company founded in 1997. The firm specializes in the development and manufacturing of transdermal therapeutic systems, providing innovative drug delivery solutions that enhance patient compliance and treatment effectiveness. With a workforce of around 220 specialists, Luye Pharma operates a state-of-the-art facility dedicated to transdermal patch production. The company serves as a trusted partner to numerous pharmaceutical firms, offering contract development and licensing services for their self-developed products. Their portfolio includes transdermal patches for various indications, such as pain management and dementia treatment. As part of the larger Luye Life Sciences Group, they are well-positioned to meet the needs of the global pharmaceutical market, focusing on patient-centered solutions and continuous improvement in drug delivery technologies.

10. Corium Innovations

• Website: coriuminv.com
• Ownership type: Private Equity
• Headquarters: Grand Rapids, Michigan, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $100.0M, October 2022
• Founded year: 1999
• Headcount: 51-200
• LinkedIn: coriuminnovations

Corium Innovations, based in Grand Rapids, Michigan, is a pharmaceutical company that specializes in innovative drug delivery technologies. Established in 1999, the company focuses on developing and manufacturing transdermal and oral thin film products designed to enhance patient adherence to medication. Corium's clientele includes pharmaceutical companies and healthcare providers seeking advanced solutions for drug delivery. The company operates as a fully integrated Contract Development and Manufacturing Organization (CDMO), offering a full range of development and manufacturing capabilities. Corium is recognized for its pioneering Corplex® technology, which has led to the creation of various transdermal systems, including the first 7-day continuous treatment patch for Alzheimer’s disease. With a strong emphasis on research and development, Corium holds over 90 patents related to drug delivery technologies. In October 2022, the company secured $100 million in funding, indicating its ongoing relevance and activity in the pharmaceutical industry.

11. Sparsha Pharma International Pvt. Ltd.

• Website: sparsha.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 100%
• Founded year: 2008
• Headcount: 51-200
• LinkedIn: sparsha-pharma-international-private-limited

Sparsha Pharma International Pvt. Ltd., based in Hyderabad, Telangana, India, is a pharmaceutical company that specializes in transdermal drug delivery systems. Established in 2008, Sparsha Pharma has positioned itself as a pioneer in this field, being the first company in India to manufacture transdermal patches. The company focuses on developing and producing a variety of therapeutic patches, including those for fentanyl, nicotine, and other medications aimed at pain management and smoking cessation. With a workforce of around 54 employees, Sparsha Pharma is dedicated to research and development, ensuring that their products meet international quality standards. Their manufacturing facilities are equipped to produce millions of patches annually, catering to both domestic and international markets. Sparsha Pharma's commitment to innovation and patient care is evident in their product offerings and their approach to improving the quality of life for patients in need of transdermal therapies.

12. Meddrop BioMedical Technologies GmbH

• Website: meddrop.com
• Ownership type: Private
• Headquarters: Hamburg, Hamburg, Germany
• Employee distribution: Germany 93%, Italy 7%
• Latest funding: Other (Grant), $55,000, June 2015
• Founded year: 2009
• Headcount: 11-50
• LinkedIn: meddrop-gmbh

Meddrop BioMedical Technologies GmbH, based in Hamburg, Germany, is a biomedical company founded in 2009. The firm specializes in innovative transdermal application technologies aimed at both medical and cosmetic products. Their proprietary TDA (Transdermal Application) technology allows for non-invasive and pain-free delivery of active ingredients deep into the skin, addressing various conditions in dermatology, pain management, and veterinary medicine. Meddrop serves a range of clients, including dermatologists, veterinarians, and consumers, emphasizing effective treatment solutions. The company has also engaged in collaborative research with universities and clinical partners, enhancing its credibility and innovation in the life sciences sector. Meddrop has received funding through grants, indicating support for its research initiatives and product development.

13. Vaxess Technologies

• Website: vaxess.com
• Ownership type: Venture Capital
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: $9.0M, April 2025
• Founded year: 2012
• Headcount: 11-50
• LinkedIn: vaxess-technologies

Vaxess Technologies, founded in 2012 and based in Boston, Massachusetts, is a biotechnology company dedicated to revolutionizing the delivery of vaccines and therapeutics. Their flagship product, the MIMIX™ transdermal patch, utilizes advanced biomaterials to provide a needle-free and refrigeration-free method for administering various medical treatments. This innovative approach not only enhances the effectiveness of vaccines but also makes them more accessible, particularly in settings where traditional cold-chain logistics are challenging. Vaxess collaborates with healthcare providers and pharmaceutical partners to expand the reach of their technology. The company has attracted significant venture capital, including a recent $9 million funding round, which underscores its potential in the transdermal drug delivery space. Vaxess is committed to improving patient experiences and outcomes through its cutting-edge delivery systems.

14. ARx, LLC

• Website: arxpharma.com
• Ownership type: Private
• Headquarters: Glen Rock, Pennsylvania, United States (USA)
• Employee distribution: United States (USA) 100%
• Founded year: 2005
• Headcount: 51-200
• LinkedIn: arx_llc

ARx, LLC, based in Glen Rock, Pennsylvania, is a pharmaceutical manufacturer that specializes in drug delivery systems. Established in 2005 as a subsidiary of Adhesives Research Inc., ARx focuses on developing and producing oral thin films and transdermal patches. The company partners with both generic and branded drug companies to create FDA-approved products that improve patient compliance and therapeutic outcomes. With a commitment to quality and innovation, ARx offers a range of services from drug product development to commercial manufacturing. Their expertise in dissolvable films and transdermal patches is supported by a robust understanding of polymer science, allowing them to meet the specific needs of their clients in the pharmaceutical industry.

15. Nanopass Technologies Ltd.

• Website: nanopass.com
• Ownership type: Venture Capital
• Headquarters: Ness Ziona, Center, Israel
• Employee distribution: Israel 100%
• Latest funding: Seed, $4.0M, July 2024
• Founded year: 2000
• Headcount: 11-50
• LinkedIn: nanopass-technologies-ltd-

Nanopass Technologies Ltd., founded in 2000 and based in Ness Ziona, Israel, is a medical device company that specializes in intradermal delivery systems. The company is known for its MicronJet™ technology, which offers a highly effective and virtually pain-free method for delivering therapeutics and aesthetic products directly into the skin. This technology is particularly appealing to healthcare professionals and aesthetic clinics, as it enhances patient comfort and treatment efficacy. With a focus on innovation, NanoPass has conducted extensive clinical research, resulting in over 70 studies that validate the effectiveness of its products. The company is FDA cleared and holds CE and ISO 13485 certifications, ensuring compliance with international standards. Recently, NanoPass secured $4 million in seed funding in July 2024, reflecting continued investor confidence in its growth potential and product offerings.

16. Altergon Italia

• Website: altergon.it
• Ownership type: Private
• Headquarters: Morra De Sanctis, Campania, Italy
• Employee distribution: Italy 100%
• Founded year: 2000
• Headcount: 201-500
• LinkedIn: altergon-italia

Altergon Italia S.r.l. Unipersonale, founded in 2000 and based in Morra De Sanctis, Campania, Italy, is a private pharmaceutical manufacturer. The company is dedicated to the production of medicated patches and ultra-pure hyaluronic acid, focusing on innovative drug delivery systems. Altergon Italia serves pharmaceutical and healthcare organizations, ensuring high-quality therapeutic solutions. Their production includes hydrogel medicated patches and drug-in-adhesive systems, which are critical for transdermal applications. The company invests significantly in research and development, collaborating with prestigious research centers and universities to enhance their product offerings. Their commitment to quality is reflected in their certifications, including ISO standards for quality management and medical devices.

17. NAL Pharma/IA Capital

• Website: nalpharma.com
• Ownership type: Private
• Headquarters: Hong Kong S.A.R
• Founded year: 2006
• Headcount: 51-200
• LinkedIn: nal-pharma-ia-capital

NAL Pharma, founded in 2006 and based in Hong Kong, is a private biopharmaceutical company that specializes in the development of proprietary drug delivery systems and novel dosage forms. The company collaborates with pharmaceutical firms to enhance drug delivery methods and improve patient compliance across various therapeutic areas, including oncology, pain management, and central nervous system disorders. NAL Pharma's innovative technologies include the Bio-D3 transdermal patch system, which utilizes proprietary skin penetration enhancers to facilitate drug absorption. This technology allows for a range of patch delivery systems that can provide localized action or systemic effects over extended periods. NAL Pharma actively seeks partnerships with major pharmaceutical companies to advance drug delivery systems for new drug entities and improve existing formulations. Their focus on enhancing the quality attributes of drug products, such as stability and solubility, underscores their commitment to innovation in the biopharmaceutical industry.

18. Fidia Pharma

• Website: fidiapharma.com
• Ownership type: Corporate
• Headquarters: Abano Terme, Italy
• Employee distribution: Italy 76%, Egypt 7%, Spain 2%, Other 15%
• Latest funding: December 2009
• Founded year: 1946
• Headcount: 1001-5000
• LinkedIn: fidia-farmaceutici-spa

Fidia Farmaceutici S.p.A., founded in 1946 and based in Abano Terme, Italy, is a pharmaceutical company that specializes in creating innovative healthcare solutions. The company focuses on therapeutic areas such as Joint Care, Skin Care, Eye Care, Aesthetic Care, Specialty Care, and Regenerative Care. Fidia is particularly known for its expertise in hyaluronic acid, which it utilizes in various products aimed at improving patient outcomes. The company operates globally, serving healthcare professionals, hospitals, and patients, and emphasizes research and development to enhance the efficacy and safety of its products. Fidia has a fully integrated approach, managing the entire production chain from research to manufacturing and marketing. Their capabilities include the production of topical dermatology products, injectables, and transdermal patches, showcasing their commitment to advancing drug delivery technologies.

19. DEC International NZ Limited

• Website: decnz.com
• Ownership type: Private
• Headquarters: Hamilton, Waikato, New Zealand
• Employee distribution: New Zealand 100%
• Founded year: 1986
• Headcount: 51-200
• LinkedIn: dechealthcare

DEC International NZ Limited, based in Hamilton, New Zealand, is a private biotech manufacturer founded in 1986. The company specializes in the development and production of drug delivery devices, particularly focusing on controlled release technologies. With a workforce of around 66 employees, DEC partners with biotech firms to provide expertise in the design and manufacturing of devices that deliver potent drugs effectively. Their capabilities include the production of transdermal, subdermal, and intracavitary silicone and polymeric devices, which are essential for slow-release drug delivery. DEC has achieved FDA approval and adheres to stringent quality management practices, ensuring compliance with regulatory standards. Their commitment to innovation and excellence in manufacturing positions them as a significant player in the drug delivery industry.

20. Navin Saxena Research and Technology Private Limited

• Website: nsrtc.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 100%
• Founded year: 2016
• Headcount: 201-500
• LinkedIn: navin-saxena-research-and-technology-private-limited

Navin Saxena Research and Technology Private Limited (NSRTC) is a pharmaceutical research firm based in Mumbai, India, founded in 2016. The company operates from the Kandla Special Economic Zone in Gujarat and employs a team of around 56 professionals. NSRTC specializes in the development of innovative drug delivery systems and active pharmaceutical ingredients (APIs). Their services cater to pharmaceutical companies and research organizations, providing advanced research and manufacturing capabilities. Notably, NSRTC has a strong focus on transdermal and topical patch technology, which is a significant aspect of their product offerings. They are also involved in contract research and development, as well as contract manufacturing services, ensuring they meet the needs of their clients in the pharmaceutical industry. The company is ISO 9001:2015 certified, reflecting their commitment to quality in their operations.

21. Hangzhou SoliPharma Co. Ltd

• Website: solipharma.com
• Ownership type: Private
• Headquarters: Hangzhou, Zhejiang, China
• Employee distribution: China 100%
• Founded year: 2010
• Headcount: 51-200
• LinkedIn: solipharma-cn

Hangzhou SoliPharma Co. Ltd, founded in 2010 and based in Hangzhou, Zhejiang, China, is a private pharmaceutical company that focuses on the development and manufacturing of innovative drug delivery systems, particularly for skin health. The company offers a variety of services, including technical support, manufacturing, and compliance, primarily targeting healthcare providers and pharmaceutical companies. SoliPharma has made significant strides in the field of transdermal drug delivery, with a commitment to quality and adherence to regulatory standards, as evidenced by their FDA approvals. Their expertise includes crystal form research and the development of semi-solid controlled-release formulations, positioning them as a notable player in the industry. The company operates under a robust quality management system, ensuring that their products meet international standards. With a dedicated workforce and a clear mission to enhance skin health through innovative solutions, SoliPharma is actively contributing to advancements in drug delivery technologies.

22. Uneedle

• Website: uneedle.com
• Ownership type: Venture Capital
• Headquarters: Enschede, Overijssel, Netherlands
• Employee distribution: Netherlands 100%
• Latest funding: $5.4M, September 2020
• Founded year: 2008
• Headcount: 11-50
• LinkedIn: uneedle

Uneedle, based in Enschede, Netherlands, is a medical device manufacturer founded in 2008. The company specializes in advanced injection technologies, particularly through its innovative products like Bella-mu and Bella-Vue. Bella-mu is designed for intradermal injections, allowing for precise delivery of up to 1 mL, which is particularly beneficial for cancer vaccines and other therapies. Bella-Vue targets the suprachoroidal space for ophthalmic drug delivery, addressing conditions affecting the retina. Uneedle's products are ISO13485 certified and have received CE marking and FDA approval, ensuring compliance with high-quality standards. The company has also secured funding of €5.39 million in 2020, which supports its ongoing development and collaboration with pharmaceutical companies and healthcare providers.

23. Nemera

• Website: nemera.net
• Ownership type: Private Equity
• Headquarters: Fontaines-Sur-Saône, Auvergne-Rhône-Alpes, France
• Employee distribution: France 61%, United States (USA) 19%, Brazil 10%, Other 11%
• Latest funding: October 2018
• Founded year: 2015
• Headcount: 1001-5000
• LinkedIn: nemera

Nemera, founded in 2015 and based in Fontaines-Sur-Saône, France, is a medical device manufacturer that specializes in drug delivery device solutions and combination product services. The company collaborates with pharmaceutical, biotechnology, and generic industries to improve treatment outcomes and ensure safe medication delivery. Their offerings include device development, clinical manufacturing, and innovation support. Nemera's product portfolio includes various drug delivery systems, such as dermal applications, which are directly relevant to transdermal drug delivery. With a workforce of approximately 1,390 employees, the company operates globally, with significant presence in France, the United States, Brazil, Germany, and Poland. Their commitment to quality and patient-centric solutions positions them as a notable player in the drug delivery device market.

24. RiconPharma India Pvt Ltd

• Website: riconpharma.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 98%, United States (USA) 2%
• Latest funding: $4.7M, November 2005
• Founded year: 2008
• Headcount: 201-500
• LinkedIn: riconpharma-india-pvt-ltd

RiconPharma India Pvt Ltd, established in 2008, operates as a pharmaceutical development company based in Hyderabad, Telangana. The company specializes in research and development of drug delivery systems and formulation services, catering to pharmaceutical businesses and organizations. RiconPharma offers expertise in pre-formulation, formulation development, and regulatory submissions, facilitating the successful launch of new drugs. Their capabilities include the development of solid oral dosages, topicals, liquids, and notably, transdermal systems. The company has a strong focus on innovative drug delivery technologies and has been involved in numerous ANDA submissions, showcasing their commitment to advancing pharmaceutical formulations. RiconPharma's facility in India is part of a broader operational framework that includes a base in Denville, NJ, USA, highlighting their international reach and collaborative potential in the pharmaceutical industry.

Transdermal Drug Delivery Insights: Key Companies

Want to Find More Transdermal Drug Delivery Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!